Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4089999

CC(C)NC(=O)Nc1ccc(Cl)c(NC2=NC(=O)C(=Cc3ccc4ncccc4c3)S2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK3 O43781 3/20 0.38
NPC1 O15118 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
CISD1 Q9NZ45 1/20 0.36
RAB9A P51151 2/20 0.36
PIK3CD O00329 1/20 0.36
PIM1 P11309 1/20 0.36
CSNK2A2 P19784 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CG P48736 1/20 0.36
CLK1 P49759 1/20 0.36
CLK3 P49761 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
DYRK1A Q13627 1/20 0.36
HASPIN Q8TF76 1/20 0.36
DYRK2 Q92630 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4089992 1.00 DYRK3 (0.38) DYRK3NPC1MEN1MAPTKMT2A
SCHEMBL2993877 0.95 NPC1 (0.41) DYRK3NPC1MEN1MAPTKMT2A
SCHEMBL2993879 0.95 NPC1 (0.41) DYRK3NPC1MEN1MAPTKMT2A
Trifluoroacetic Acid SCHEMBL4089200 0.91 DYRK3 (0.39) DYRK3NPC1MEN1MAPTKMT2A
Trifluoroacetic Acid SCHEMBL4089207 0.91 DYRK3 (0.39) DYRK3NPC1MEN1MAPTKMT2A
Trifluoroacetic Acid SCHEMBL4095087 0.88 PABPC1 (0.48) DYRK3NPC1MAPTPOLBRAB9A
Trifluoroacetic Acid SCHEMBL4095081 0.88 PABPC1 (0.48) DYRK3NPC1MAPTPOLBRAB9A
Trifluoroacetic Acid SCHEMBL4093780 0.86 TRPV1 (0.42) DYRK3NPC1MEN1MAPTKMT2A
Trifluoroacetic Acid SCHEMBL4093784 0.86 TRPV1 (0.42) DYRK3NPC1MEN1MAPTKMT2A
SCHEMBL2996481 0.86 DYRK3 (0.42) DYRK3NPC1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 DYRK3 1471/4885NPC1 2040/4885MEN1 3889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.